ASTH Q1 Deep Dive: AI-Enabled Platform, Full-Risk Expansion, and Operating Leverage Shape Results
Astrana Health (NASDAQ:ASTH) executives highlighted strong first-quarter 2026 results and reaffirmed full-year guidance, pointing to disciplined growth, continued deleveraging, and early performance of...
Astrana Health (NASDAQ:ASTH) Beats Q1 CY2026 Sales Expectations
Company to Host Conference Call on Thursday, May 7, 2026, at 2:30 p.m. PT/5:30 p.m. ET
Barchart Research What to Expect from ASTH Earnings ASTH Generated May 6, 2026 Current Price $35.25 EPS Estimate $$0.29 Consensus Rating Moderate Buy Average Move 15.14% Astrana Health Reports Earnings...
Astrana Health (ASTH) Q1 Earnings Report Preview: What To Look For
2 Profitable Stocks on Our Watchlist and 1 Facing Headwinds
1 Healthcare Stock to Target This Week and 2 We Ignore
ALHAMBRA, Calif. , April 21, 2026 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: ASTH), a physician-centric,...
1 Surging Stock with Competitive Advantages and 2 We Ignore